Kunming Longjin Pharmaceutical Co., Ltd.

SZSE:002750.SZ

9.92 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 7.11513.02925.615.56927.41922.0821.55420.18624.66830.54547.566108.71196.271191.418206.1289.64363.8859.13341.37187.0457.10265.93765.21384.25984.08184.79582.8589.38282.39973.23759.42972.22157.24449.5644.60644.97143.21346.57346.67157.47743.16447.7339.031
Cost of Revenue 1.6872.868.14811.7438.9226.5086.7097.3724.5444.1479.50861.187139.916132.169150.97428.3197.7469.2576.02725.748.8368.8284.8599.9928.4258.1726.5579.6137.6428.7747.9811.4288.86512.81311.92514.05716.26917.59915.06518.85910.54914.2714.091
Gross Profit 5.42810.16917.4523.82618.49815.57214.84512.81420.12426.39838.05847.52256.35459.24955.14761.32356.13449.87635.34461.348.26657.10960.35474.26875.65576.62376.29379.76974.75764.46351.44960.79348.37936.74732.68130.91426.94528.97431.60638.61832.61533.45924.94
Gross Profit Ratio 0.7630.780.6820.2460.6750.7050.6890.6350.8160.8640.80.4370.2870.310.2680.6840.8790.8430.8540.7040.8450.8660.9250.8810.90.9040.9210.8920.9070.880.8660.8420.8450.7410.7330.6870.6240.6220.6770.6720.7560.7010.639
Reseach & Development Expenses 0.3683.2661.9929.4594.6733.9744.1159.8214.7336.5313.8668.0364.5111.585.463.2317.5513.015.8076.693.9966.8743.1239.619.33711.082.27132.6211.56610.22409.476.1945.41902.9772.7773.78309.46403.7820
General & Administrative Expenses 0-2.6395.733-13.62517.887-1.4016.947-10.94515.854-1.875.991-17.72920-2.178.198-13.0316.379-3.4386.311-8.646.72-2.4385.264-16.97714.971-3.8187.753-29.57817.424-5.33410.66-21.50412.299-4.6110.329-17.0718.533-2.0629.673-17.4059.6238.7027.843
Selling & Marketing Expenses 06.29617.30416.04720.20914.74113.73315.44616.63220.53727.91836.41843.2145.3740.12643.244.01240.94329.82742.52942.05952.34345.21767.02252.17962.16361.24460.11253.28242.43626.97527.36519.7266.974.4147.081.9372.3123.3045.8212.0235.8723.177
SG&A 10.2913.65723.6542.42238.09613.3420.6794.50132.48618.66733.9118.68963.21143.248.32330.16850.39137.50536.13833.88948.77949.90450.48250.04567.14958.34668.99730.53470.70637.10237.6355.86132.0252.3614.743-9.99110.470.2512.977-11.58411.64614.57411.02
Other Expenses -0.0634.20400.897-0-00.17219.083-10.3417.9560.382-0.004-0.060.001-0.001-0.021-0.149-0.163-1.041-0.4430.005-00.005-1.016-0.88319.475-0.001-8.473.9590.4553.0553.1420.8060.5040.4335.5240.7231.130.450.430.4371.1250.313
Operating Expenses 10.72215.66525.64629.51733.55926.48524.96633.40526.87833.15338.15751.75556.89356.62254.44947.86456.78851.54642.53254.7951.91164.30254.72776.56575.09277.82169.31367.05772.66555.96739.0746.95833.07317.84815.5118.59111.14813.57813.67515.59912.65615.37411.665
Operating Income -5.294-1.143-8.194-50.573-13.62-8.737-9.005-50.446-6.754-6.755-0.21-7.9321.640.3720.46410.2251.8511.297-4.729-25.488-0.008-3.567.1020.5783.7744.4597.88514.9263.47610.50712.89416.22841.52720.66718.71714.94817.13615.68917.15322.59619.58117.84213.355
Operating Income Ratio -0.744-0.088-0.32-3.248-0.497-0.396-0.418-2.499-0.274-0.221-0.004-0.0730.0080.0020.0020.1140.0290.022-0.114-0.293-0-0.0540.1090.0070.0450.0530.0950.1670.0420.1430.2170.2250.7250.4170.420.3320.3970.3370.3680.3930.4540.3740.342
Total Other Income Expenses Net 0.7330.2042.187-27.625-0-00.1-12.3363.1932.9771.602-0.0482.118-2.254-0.001-3.2122.3562.8041.419-32.4423.6413.6341.481.8593.2115.6560.904-6.2565.3442.4663.575.53527.0272.2721.9798.1492.0631.313-0.3280.0070.0580.8820.393
Income Before Tax -4.562-0.939-6.007-50.979-13.62-8.737-8.905-62.782-3.561-3.7781.392-7.981.580.3730.46310.2471.7021.133-5.77-25.932-0.004-3.567.107-0.4393.7744.4597.8836.4567.43510.96315.94919.3742.33321.17119.1520.47217.85916.7117.60323.02520.01818.96713.668
Income Before Tax Ratio -0.641-0.072-0.235-3.274-0.497-0.396-0.413-3.11-0.144-0.1240.029-0.0730.0080.0020.0020.1140.0270.019-0.139-0.298-0-0.0540.109-0.0050.0450.0530.0950.0720.090.150.2680.2680.740.4270.4290.4550.4130.3590.3770.4010.4640.3970.35
Income Tax Expense 0.6740.817-0.630.8860.340.2830.512.3080.4021.3880.7022.750.66-0.769-0.745-0.733-0.3180.2880.321-1.2660.5940.3241.8960.2570.1730.7780.6411.9440.1291.5092.0621.8762.6353.3723.142.7252.9162.342.92.7133.2953.4382.659
Net Income -5.1060.268-4.492-44.299-10.865-7.66-9.415-65.089-3.962-5.1660.832-3.4791.72.2372.6369.5273.8912.583-4.189-24.6570.209-3.8975.237-0.6543.6013.687.2424.457.3079.45513.94717.52839.69817.79916.0117.78514.94314.3714.70320.31316.72315.52911.009
Net Income Ratio -0.7180.021-0.175-2.845-0.396-0.347-0.437-3.224-0.161-0.1690.017-0.0320.0090.0120.0130.1060.0610.044-0.101-0.2830.004-0.0590.08-0.0080.0430.0430.0870.050.0890.1290.2350.2430.6930.3590.3590.3950.3460.3090.3150.3530.3870.3250.282
EPS -0.0130.001-0.011-0.11-0.027-0.019-0.024-0.16-0.01-0.0130.002-0.0090.0040.0060.0070.0240.010.007-0.011-0.060.001-0.010.013-0.0020.0090.0090.0180.0110.0180.0240.0350.0440.0990.0440.040.0440.0370.0480.0490.0680.0560.0520.037
EPS Diluted -0.0130.001-0.011-0.11-0.027-0.019-0.024-0.16-0.01-0.0130.002-0.0090.0040.0060.0070.0240.010.007-0.011-0.0590.001-0.010.013-0.0020.0090.0090.0180.0110.0180.0240.0350.0440.0990.0440.040.0440.0370.0480.0490.0680.0560.0520.037
EBITDA -4.51-0.255-6.0380.544-18.307-8.053-9.698-23.474-11.897-2.8010.037-1.2311.493.4593.21518.820.673-2.863-7.26341.04-4.343-8.0196.421-2.1140.208-1.2827.08815.1742.8878.7512.61751.01315.35623.35317.02923.93415.78116.90118.38831.419.9518.08513.275
EBITDA Ratio -0.634-0.02-0.2360.035-0.668-0.365-0.45-1.163-0.482-0.0920.001-0.0110.0080.0180.0160.210.011-0.048-0.1760.472-0.076-0.1220.098-0.0250.002-0.0150.0860.170.0350.1190.2120.7060.2680.4710.3820.5320.3650.3630.3940.5460.4620.3790.34